Acute electronic cigarette use: nicotine delivery and subjective effects in regular users
- 3.3k Downloads
Electronic cigarettes are becoming increasingly popular among smokers worldwide. Commonly reported reasons for use include the following: to quit smoking, to avoid relapse, to reduce urge to smoke, or as a perceived lower-risk alternative to smoking. Few studies, however, have explored whether electronic cigarettes (e-cigarettes) deliver measurable levels of nicotine to the blood.
This study aims to explore in experienced users the effect of using an 18-mg/ml nicotine first-generation e-cigarette on blood nicotine, tobacco withdrawal symptoms, and urge to smoke.
Fourteen regular e-cigarette users (three females), who are abstinent from smoking and e-cigarette use for 12 h, each completed a 2.5 h testing session. Blood was sampled, and questionnaires were completed (tobacco-related withdrawal symptoms, urge to smoke, positive and negative subjective effects) at four stages: baseline, 10 puffs, 60 min of ad lib use and a 60-min rest period.
Complete sets of blood were obtained from seven participants. Plasma nicotine concentration rose significantly from a mean of 0.74 ng/ml at baseline to 6.77 ng/ml 10 min after 10 puffs, reaching a mean maximum of 13.91 ng/ml by the end of the ad lib puffing period. Tobacco-related withdrawal symptoms and urge to smoke were significantly reduced; direct positive effects were strongly endorsed, and there was very low reporting of adverse effects.
These findings demonstrate reliable blood nicotine delivery after the acute use of this brand/model of e-cigarette in a sample of regular users. Future studies might usefully quantify nicotine delivery in relation to inhalation technique and the relationship with successful smoking cessation/harm reduction.
KeywordsNicotine delivery Electronic cigarette Acute use Urge to smoke Tobacco withdrawal symptoms Abstinent smokers Smoking cessation Nicotine addiction
- Gao J, Sanchez-Medina A, Pendry BA, Hughes MJ, Webb GP, Corcoran O (2008) Validation of a HPLC method for flavonoid biomarkers in skullcap (Scutellaria) and its use to illustrate wide variability in the quality of commercial tinctures. J Pharm Pharmacol Sci 11:77–87Google Scholar
- McEwen A, West R, Gaiger M (2008) Nicotine absorption from seven current nicotine replacement products and a new wide-bore nicotine delivery device. J Smok Cessat 3:117–123Google Scholar
- MHRA (2013). The regulation of nicotine containing products (NCPs) 12 June 2013. http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Product-specificinformationandadvice/Product-specificinformationandadvice%E2%80%93M%E2%80%93T/NicotineContainingProducts/index.htm. Accessed 19 Aug 2013
- Royal College of Physicians (2000) Nicotine addiction in Britain. Royal College of Physicians, LondonGoogle Scholar
- Sanchez-Medina A, Etheridge CE, Hawkes GE, Hylands PJ, Pendry BA, Hughes MJ, Corcoran O (2007) Comparison of rosmarinic acid content in commercial tinctures produced from fresh and dried lemon balm (Melissa officinalis). J Pharm Pharmacol Sci 10:455–463Google Scholar
- The NHS Information Centre (2011) Lifestyles statistics. Statistics on Smoking, England. http://www.hscic.gov.uk/pubs/smoking11. Accessed 19 Aug 2013